Japan
Deep-built9% circumcision prevalence
Prevalence of non-therapeutic male circumcision.
Research coverage
A transparent snapshot of what this file currently contains.
8
Sources · Citations
8
Verifications · Independent
5
Structured claims · Evidence-based
Jul 9, 2026
Last updated · deep-built
Research note: Japan built out as a Phase 2 large-population low-prevalence burst (Jun 2026): full build closing all four gaps (M2 HIV, H1 write-up, L1/L3/L4 curated legal, S1/S2 sources). 8 graded sources (#223–230), 5 claims, a deep write-up, 1 verified aggregate incident (Kokusen consumer complaints). THE no-tradition / CONSUMER-HARM case (unique in the dataset): circumcision is rare (~9%) with no religious/infant/rite tradition (the intact penis is the norm); where it happens it is elective COSMETIC surgery at private beauty clinics framed around masculinity, not health. The distinctive harm is the "kanton hokei" predatory-marketing scandal — clinics pathologise the normal foreskin as pseudo-phimosis and bait-and-switch young men (¥70k–100k → ¥800k–1.8M); Japan's National Consumer Affairs Center (Kokusen) logged 1,092 complaints (59% men in their 20s) + alerts 2016/2019; lawyers' victims' team 2016. Japanese pediatric urology is conservative (foreskin retracts by adolescence; Kayaba 1996). HONEST-FRAMING: 9% is a modelled single-survey estimate; "no statute" is evidence-of-absence; the live regulation is consumer protection not a circumcision ban; HIV very low (0.006–0.115%, exact UNAIDS value not pinned); harm is financial/medical-ethics aggregate, not clinical complication data. DEEP_BUILT.
Research claims
Short, testable claims backed by evidence and categorised for clarity.
Circumcision is rare in Japan, with no religious or routine tradition
Japan is a low-prevalence country (~9%, from a self-report survey) with no routine infant, religious, or rite-of-passage circumcision — "neonatal circumcision has never been mandatory and no official records exist." The intact penis is the cultural norm.
The 9% is a modelled estimate from a single small survey (n=188, Kanagawa), not a national census.
Japanese pediatric urology treats the foreskin conservatively
Japanese pediatric urology favours nonoperative management of the foreskin: physiological non-retractability is normal in childhood and resolves naturally by adolescence (retractability rises from 0% in infancy to ~63% by ages 11–15), so circumcision for it is unnecessary — explicitly to "eliminate unnecessary circumcision in boys."
Where it happens, Japanese circumcision is elective cosmetic surgery, not disease prevention
In Japan circumcision is performed mainly on adult men at private beauty/aesthetic clinics, marketed as a way to "regain control of the body and enhance self-confidence" and boost masculinity — not for health. References to circumcision for disease prevention are "almost completely absent" from how Japanese men frame it.
The framing finding is from a small qualitative study (n=26); it documents how the practice is understood, not national prevalence.
Japan is very low-prevalence for HIV and does not use circumcision for prevention
Japan has very low HIV prevalence (estimates 0.006–0.115%, all well below the low-prevalence threshold), and circumcision is not promoted for HIV/STI prevention nor part of any Japanese health strategy — consistent with disease-prevention being absent from how the practice is framed there.
HIV estimates vary widely due to surveillance gaps; the exact current single-year UNAIDS value was not pinned. Context, not a causal claim.
Predatory "phimosis clinics" pathologise the normal foreskin and upsell expensive surgery
Japanese cosmetic clinics pathologise the normal retractable foreskin as "kanton hokei" (pseudo-phimosis) and bait-and-switch young men into expensive elective circumcision — advertised at ¥70,000–100,000 but escalating to ¥800,000–1,800,000. It is an officially-recognised consumer-protection problem: the National Consumer Affairs Center logged 1,092 complaints (most from men in their 20s) and issued formal alerts in 2016 and 2019.
The harm here is primarily financial/consumer + medical-ethics, documented via complaint aggregates rather than clinical outcome data.
Legal status
UnregulatedJapan has no statute regulating or restricting non-therapeutic male circumcision of minors — it is simply uncommon, with no religious or routine tradition. The notable regulatory story is the opposite of a ban: official CONSUMER-PROTECTION action against predatory cosmetic "phimosis clinics" that upsell elective circumcision to young men.
No Japanese law sets a minimum age for, regulates, or prohibits non-therapeutic male circumcision; it is a legally unaddressed, uncommon elective procedure (evidence-of-absence finding, held at medium confidence). The substantive state involvement is consumer protection: Japan's National Consumer Affairs Center (Kokusen 国民生活センター, under the Consumer Affairs Agency) issued formal advisories on 23 June 2016 ("Problems with Phimosis Surgery in Cosmetic Medical Services") and 21 November 2019, after logging 1,092 phimosis-surgery (包茎手術) complaints — most from men in their 20s — over predatory bait-and-switch pricing (advertised ¥70,000–100,000 escalating to ¥800,000–1,800,000) and pressure to undergo unnecessary surgery. A lawyers' "Phimosis Surgery Victims Countermeasures Legal Defense Team" (包茎手術被害対策弁護団) formed in 2016 and has pursued litigation/settlements. The harm in Japan is therefore primarily financial/consumer and medical-ethics, not a religious or mass-circumcision harm. Status UNREGULATED reflects the absence of a circumcision statute; the practice is rare and the live regulatory front is consumer protection.
Medical & HIV context
0.1%
Adult HIV prevalence
National (2023) · Adults 15–49
rare
Circumcision in newborns
Non-therapeutic (cultural practice)
Adulthood (elective cosmetic); no infant/rite tradition
Typical age
Benchmarks are international context — not a local complication rate.
Incident registry
No verified incidents are currently recorded for Japan.
This absence should not be read as proof that harm does not occur — only that no verified, sourced case has been documented in this database yet.